Deferoxamine mesylate en es it fr

Deferoxamine mesylate Brand names, Deferoxamine mesylate Analogs

Deferoxamine mesylate Brand Names Mixture

  • No information avaliable

Deferoxamine mesylate Chemical_Formula

C20H29N3O2

Deferoxamine mesylate RX_link

No information avaliable

Deferoxamine mesylate fda sheet

Deferoxamine mesylate msds (material safety sheet)

Deferoxamine_mesylate MSDS

Deferoxamine mesylate Synthesis Reference

No information avaliable

Deferoxamine mesylate Molecular Weight

343.463 g/mol

Deferoxamine mesylate Melting Point

99-101oC (HCl salt)

Deferoxamine mesylate H2O Solubility

42 mg/L

Deferoxamine mesylate State

Solid

Deferoxamine mesylate LogP

3.588

Deferoxamine mesylate Dosage Forms

Ointment

Deferoxamine mesylate Indication

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.

Deferoxamine mesylate Pharmacology

Dibucaine is an amide-type local anesthetic, similar to lidocaine.

Deferoxamine mesylate Absorption

In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.

Deferoxamine mesylate side effects and Toxicity

Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.

Deferoxamine mesylate Patient Information

No information avaliable

Deferoxamine mesylate Organisms Affected

Humans and other mammals